Adalimumab originator and biosimilars in global inflammatory bowel disease treatment

被引：0
|
作者：
Yiu, Tsz Hong [1 ]
Nakase, Hiroshi [3 ]
Leung, Wai Keung [4 ]
Lin, Huiyu [5 ]
Banerjee, Rupa [6 ,7 ]
Anderson, Emilia [2 ]
Leong, Rupert [2 ]
机构：
[1] Western Hlth, Melbourne, Vic, Australia
[2] Concord Repatriat Gen Hosp, Sydney, NSW, Australia
[3] Sapporo Med Univ, Sapporo, Hokkaido, Japan
[4] Univ Hong Kong, Pok Fu Lam, Hong Kong, Peoples R China
[5] Tan Tock Seng Hosp, Singapore, Singapore
[6] Asian Inst Gastroenterol, Gachibowli, India
[7] AIG Hosp, Gachibowli, India
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
101
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [41] Adalimumab in childhood inflammatory Bowel disease
    Noc, J. D.
    Pfefferkorn, M. D.
    PEDIATRIC RESEARCH, 2007, 62 (04) : 521 - 521
  • [42] The use of biosimilars in paediatric inflammatory bowel disease
    Jongsma, Maria Myrthe Elisabeth
    Vulto, Arnold
    de Ridder, Lissy
    CURRENT OPINION IN PEDIATRICS, 2017, 29 (05) : 560 - 565
  • [43] The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease
    Avila-Ribeiro, Pedro
    Fiorino, Gionata
    Danese, Silvio
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (44) : 6759 - 6769
  • [44] Progress with infliximab biosimilars for inflammatory bowel disease
    Kurti, Zsuzsanna
    Gonczi, Lorant
    Lakatos, Peter L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (06) : 633 - 640
  • [45] Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study
    Hanzel, Jurij
    Jansen, Jeroen M.
    ter Steege, Rinze W. F.
    Gecse, Krisztina B.
    D'Haens, Geert R.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (04) : 495 - 501
  • [46] Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study
    Jose Casanova, Maria
    Nantes, Oscar
    Varela, Pilar
    Vela-Gonzalez, Milagros
    Rivero, Montserrat
    Sierra-Gabarda, Olivia
    Riestra, Sabino
    Barreiro-de Acosta, Manuel
    del Mar Martin-Rodriguez, Maria
    Jerusalen Gargallo-Puyuelo, Carla
    Reygosa, Cristina
    Munoz, Roser
    Garcia de la Filia-Molina, Irene
    Nunez-Ortiz, Andrea
    Kolle, Lilyan
    Calafat, Margalida
    Maria Huguet, Jose
    Iglesias-Flores, Eva
    de Jesus Martinez-Perez, Teresa
    Bosch, Orencio
    Maria Duque-Alcorta, Jose
    Frago-Larramona, Santiago
    Van Domselaar, Manuel
    Manuel Gonzalez-Cosano, Victor
    Bujanda, Luis
    Rubio, Saioa
    Mancebo, Alejo
    Castro, Beatriz
    Garcia-Lopez, Santiago
    de Francisco, Ruth
    Nieto-Garcia, Laura
    Laredo, Viviana
    Gutierrez-Casbas, Ana
    Mesonero, Francisco
    Leo-Carnerero, Eduardo
    Canete, Fiorella
    Ruiz, Lucia
    Gros, Beatriz
    del Moral-Martinez, Maria
    Rodriguez, Cristina
    Chaparro, Maria
    Gisbert, Javier P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (01) : 60 - 70
  • [47] Safety of biosimilars compared with originator adalimumab for psoriasis: a multinational cohort study
    Phan, Duc Binh
    Jourdain, Hugo
    Descalzo-Gallego, Miguel Angel
    Gonzalez-Quesada, Alicia
    Zureik, Mahmoud
    Rivera-Diaz, Raquel
    Sahuquillo-Torralba, Antonio
    Lunt, Mark
    Garcia-Doval, Ignacio
    Sbidian, Emilie
    Warren, Richard
    Yiu, Zenas
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [48] Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis
    Loft, Nikolai
    Egeberg, Alexander
    Rasmussen, Mads Kirchheiner
    Bryld, Lars Erik
    Nissen, Christoffer Valdemar
    Dam, Tomas Norman
    Ajgeiy, Kawa Khaled
    Iversen, Lars
    Skov, Lone
    JAMA DERMATOLOGY, 2021, 157 (06) : 676 - 683
  • [49] Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
    Calvo-Arbeloa, Maria
    Maria Insausti-Serrano, Ana
    Arrondo-Velasco, Amaya
    Teresa Sarobe-Carricas, Maria
    FARMACIA HOSPITALARIA, 2020, 44 (02) : 62 - 67
  • [50] Systematic Review of Evidence for Monoclonal Antibody Biosimilars for the Treatment of Inflammatory Bowel Disease
    Petersel, Danielle
    Cheung, Raymond
    Sewell, K. Lea
    Singh, Ena
    Isakov, Leah
    Jacobs, Ira
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S30 - S30
12345